pharma · Advanced solid tumors · Advanced Solid Tumors · TTRX
Turn Therapeutics
Turn Therapeutics (Nasdaq: is a pharma organization headquartered in Westlake Village, USA. It trades on NYSE under ticker TTRX. Primary therapeutic focus areas include Advanced solid tumors, Advanced Solid Tumors, Covid
Westlake Village, USA HQ
2015 Founded
11 Employees
Public company Type
TTRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Westlake Village, USA
- Founded
- 2015
- Employees
- 11
- Programs
- 6
- Drugs
- 3
- Patents
- 40
GX-03
Phase 2 · other · Eczema Atopic Dermatitis
GX-03 for Eczema Atopic Dermatitis is a Phase 2 program (other) at Turn Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code Protocol/Panel 4604
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Turn Therapeutics
- Phase
- Phase 2
- Modality
- other
- Indication
- Eczema Atopic Dermatitis
- Status
- active
- Trials
- 1